(Q34395792)

1 August 2017

1 reference

title

The importance of hyperhomocysteinemia as a risk factor for diseases: an overview (English)

1 reference

1 August 2017

0 references

W Herrmann

1

1 reference

1 August 2017

publication date

1 August 2001

1 reference

Clinical Chemistry and Laboratory Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

39

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

666-674

1 reference

1 August 2017

cites work

Homocysteine metabolism

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

The metabolism of homocysteine: pathways and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Glycine N-methyltransferase is a folate binding protein of rat liver cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine, folate, methylation, and monoamine metabolism in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Brain function in the elderly: role of vitamin B12 and folate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine and folate levels as risk factors for recurrent early pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine metabolism and the oxidative modification of proteins and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Homocysteine: the new player in the field of coronary risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

Purification, characterization and differentiation-dependent expression of a perchloric acid soluble protein from rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.110

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.110

1 reference

1 August 2017

1 reference